Back to Search
JULIUS BRECHT, M.D.
M.D.
Orthopaedic Trauma Physician
NPI: 1659435071IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery Physician
Orthopaedic Surgery
Code: 207X00000X
5276(AK)237700(MA)
Orthopaedic Foot and Ankle Surgery Physician
Orthopaedic Surgery — Foot and Ankle Surgery
Code: 207XX0004X
5276(AK)
Orthopaedic Trauma PhysicianPrimary
Orthopaedic Surgery — Orthopaedic Trauma
Code: 207XX0801X
5276(AK)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1993
Research & Publications (12)
Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
PMID 15575171·Int J Clin Pharmacol Res·2004
4-observational
Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
PMID 15224498·Int J Clin Pharmacol Res·2003
8-other
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.
PMID 17938798·Thromb Haemost·2007
8-other
Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
PMID 17610347·Am J Cardiovasc Drugs·2007
4-observational
Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.
PMID 16761905·Pharmacoeconomics·2006
8-other
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.
PMID 15853438·Pharmacoeconomics·2005
1-meta
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
PMID 15853437·Pharmacoeconomics·2005
8-other
Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
PMID 15449961·Pharmacoeconomics·2004
8-other
Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective.
PMID 15389357·Swiss Med Wkly·2004
8-other
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
PMID 14991279·Z Rheumatol·2004
4-observational
Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insurance.
PMID 11465309·Pharmacoeconomics·2001
8-other
Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.
PMID 10747764·Pharmacoeconomics·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 BIRNIE AVE, SUITE 201
SPRINGFIELD, MA 01107 - Phone
- (413) 785-4666
Quick Facts
- NPI
- 1659435071
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 33
- Publications
- 12
Are you this provider?
Claim Your Profile